Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study.

Long-term metformin use reduced all-cause mortality, but not CSS in ovarian cancer. Whether metformin itself reduces deaths because of ovarian cancer requires further investigation.